Skip to main content

California Comprehensive Compliance Program Declaration

Amylyx declares, based on our good faith understanding of the California Health and Safety Codes §§ 119400-119402, and to the best of our knowledge, that we are in substantial compliance with our Comprehensive Compliance Program (“Compliance Program”) and California Health and Safety Code §§ 119400-119402. Our Compliance Program includes the elements of an effective compliance program identified in the “Compliance Program Guidance for Pharmaceutical Manufacturers” published by the Office of the Inspector General, U.S. Department of Health and Human Services (“HHS-OIG Guidance”). Consistent with our understanding of the California Health and Safety Code, this declaration is limited to Amylyx’ activities directed to California.

Our Code of Business Conduct and Ethics is available to the public on this website. To request a copy of Amylyx’ Comprehensive Compliance Program Declaration, please contact the Amylyx Compliance hotline at 833-778-1542.

Statutory Price Disclosure for Colorado Prescribers Pursuant to Colorado House Bill 19-1131

This information in this form is being provided pursuant to Colorado HB 19-1131. The information is accurate as of November 30, 2022.